Are you a more creative or analytical thinker?

Researchers have clarified, for the first time, the mechanism behind a very rare brain disorder called MICPCH (microcephaly, disproportionate pontine and cerebellar hypoplasia) syndrome in animal models.

New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

The frontal lobe paradox.

From medicine to make-up: until recently, a common misconception was that lipids are simply fat molecules, however, recent advances in technologies used to dissect and study lipid profiles prove that this is not the whole truth.

Stem cells were first discovered in human cord blood in 1978. Why would we think they can be of more help now? This article delves into reasons behind the sudden interest in stem cells, and highlights how they can be used to advance drug discovery.

You would think that instances of proven psychic fraud over the years would weaken the credibility of psychic claims.

We interviewed Russell A. Barkley, PhD, an internationally recognized expert on attention-deficit hyperactivity disorder (ADHD), to gain an insight into the disorder, its portrayal in the media and the future of ADHD research.

At the Society for Neuroscience (SfN) conference last held in November 2018 in San Diego, a truly frightening number of posters were presented over nine sessions. In this article we look in-depth at posters shared by Charles River Laboratories, highlighting research into Huntington's Disease and Parkinson's Disease.